According to a study in the September 21 issue of JAMA says that among patients with acute coronary syndromes undergoing a procedure such as angioplasty, those who received platelet function tests ...
LOS ANGELES — Patients with intracranial aneurysm who respond poorly to the antiplatelet drug clopidogrel when treated with flow diversion using the Pipeline embolization device (Medtronic) have ...
This release is available in Chinese. An analysis of six tests that are used to measure platelet function and help gauge the effectiveness of antiplatelet drugs for patients undergoing a cardiac ...
The document follows two earlier consensus documents, released in 2013 and 2016. Dominick Angiolillo, MD, PhD (University of Florida College of Medicine – Jacksonville), senior author of the paper, ...
Use of platelet function testing during dual antiplatelet therapy, including a P2Y12 antagonist, in acute coronary syndromes does not improve clinical outcomes. Researchers at King's College London ...
Platelets are small cells in the blood responsible for clotting of the damaged blood vessels. Blood vessels are responsible for carrying blood through the body. In an event when blood vessels are ...
WASHINGTON, DC—Additional evidence, this time from a phase IIb trial in healthy people ages 50 to 80, supports that bentracimab (PhaseBio) provides a near-immediate reversal of ticagrelor’s ...
The global platelet function test market is poised for robust growth over the next decade, fueled by innovations in diagnostic technologies and increasing demand for personalized, preventive ...
Ticagrelor is an oral P2Y 12 inhibitor that is used with aspirin to reduce the risk of ischemic events among patients with acute coronary syndromes or previous myocardial infarction. Spontaneous major ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback